AI-Powered Engagement is a Minefield

Send us Fan MailAI voice tech might be the next big privacy risk for pharma marketers, and lawsuits are already in motion. In this episode of Darshan Talks, we dive into the legal challenges surrounding AI-powered voice tools in healthcare marketing, especially under California’s strict privacy laws.A federal court ruling in Ambrose v. Google suggests that recording conversations without explicit real-time consent may be illegal. This could impact pharma companies using AI voice assistants, Alexa skills, voice bots, and patient support apps. If your tech processes speech without proper disclosures, you might be violating the California Invasion of Privacy Act (CIPA)—a law with $5,000 in statutory damages per violation.For large pharma brands, non-compliance could lead to multimillion-dollar class action lawsuits. Burying consent deep in a privacy policy won’t cut it anymore—courts are demanding clear, real-time disclosure. To stay ahead, pharma marketers must audit their tech stack, collaborate with privacy law experts, and push vendors to meet compliance standards.The future of pharma marketing is controversial, and the brands that innovate responsibly will thrive. Contact the Kulkarni Law Firm to audit your voice marketing stack before the lawsuits start piling up.Support the showwww.kulkarnilawfirm.com